Business Context and Reporting Period
This Form 8-K Current Report from Boston Scientific Corporation (BSX) covers events occurring on April 30, 2026, specifically the Company's 2026 Annual Meeting of Stockholders. The report details the outcomes of shareholder votes and amendments to the Company's governing documents.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
Stockholders approved several key matters at the Annual Meeting:
- Director Elections: All 10 director nominees were elected to the Board for a one-year term.
- Executive Compensation: The advisory vote on Named Executive Officer compensation was approved.
- Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the 2026 fiscal year.
- ESPP Amendment: An amendment to the Employee Stock Purchase Plan to increase reserved shares was approved.
- Charter Amendments: Stockholders approved amendments to eliminate supermajority voting provisions and to provide for the exculpation of certain officers under Delaware law. These amendments became effective on May 5, 2026.
Stockholders rejected two proposals regarding special meetings:
- Special Meeting Rights (Management Proposal): The proposal to permit stockholders owning 25% or more of common stock to call a special meeting was not approved.
- Special Meeting Rights (Shareholder Proposal): A separate shareholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting" was also not approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors. The document serves as a notification of completed corporate actions.
Key Facts for Investor Verification
- Verify the effective date of the Fourth Restated Certificate of Incorporation (May 5, 2026) and the removal of supermajority voting provisions.
- Confirm the composition of the Board of Directors following the election of all 10 nominees.
- Note the rejection of proposals to grant shareholders the right to call special meetings, indicating current governance restrictions remain in place.
- Review the amended Employee Stock Purchase Plan (Exhibit 10.1) for details on the increased share reserve.